🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-04-27
Trial ID
NCT01113476
Treatments Being Tested
This phase II trial studies how well giving bevacizumab, radiation therapy,...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2006-07-25
Trial ID
NCT00321685
The study compares the efficacy and safety of intralesional bevacizumab ver...
Status
Active Not Recruiting
Location
Kasr El Ainy University Hospital, faculty of medicine, Cairo university
Start Date
2023-09-01
Trial ID
NCT07014280
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as bevacizumab can locate cancer cell...
Status
Completed
Location
Blood and Marrow Transplant Group of Georgia
Start Date
2001-04
Trial ID
NCT00015951
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167177
This was the cross-sectional study to assess the period prevalence of IOI i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05146687
Treatments Being Tested
This phase II trial studies the effect of atezolizumab and bevacizumab befo...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Start Date
2021-02-10
Trial ID
NCT04721132
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-09-30
Trial ID
NCT01213238
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of RP2 in co...
Status
Recruiting
Location
Beverly Hills Cancer Center
Start Date
2024-08-01
Trial ID
NCT05733598
Treatments Being Tested